DOCSLIB.ORG

Probing the Structure of Acetylcholinesterase Inhibitors in Their Binding Site Using Solid State Nuclear Magnetic Resonance

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Probing the Structure of Acetylcholinesterase Inhibitors in Their Binding Site Using Solid State Nuclear Magnetic Resonance Probing the Structure of Acetylcholinesterase Inhibitors in their Binding Site using Solid State Nuclear Magnetic Resonance Scott Goodall Submitted in partial fulfilment of the requirements for the degree of Doctor of Philosophy Christ Church, Oxford Trinity 2002 Every attempt to employ mathematical methods in the study of chemical questions must be considered profoundly irrational and contrary to the spirit of chemistry … if mathematical analysis should ever hold a prominent place in chemistry, an aberration which is happily almost impossible, it would occasion a rapid and widespread degeneration of that science. Auguste Comte (1798-1857) Abstract Probing the Structure of Acetylcholinesterase Inhibitors in their Binding Site using Solid State Nuclear Magnetic Resonance Scott Goodall, DPhil Thesis Christ Church, Trinity 2002 Inhibitors of acetylcholinesterase are of commercial and medical interest as pesticides and as therapeutics in the treatment of Alzheimer’s Disease. An understanding of the conformation of inhibitors in the binding site enables the rational design of novel inhibitors with increased potency and specificity. Solid state NMR is a novel approach to the investigation of acetylcholinesterase and the binding of acetylcholinesterase inhibitors. Two compounds, 4- amino-5-fluoro-2-methyl-3-(3-trifluoroacetylbenzyl-oxymethyl)quinoline (R414425) and 4- amino-2-methyl-3-(3-trifluoroacetylbenzyl-oxymethyl)quinoline (R414983) were selected for study from a series of structures developed by Syngenta during research into novel pesticides. The series, based around a chimera of tacrine and m-(N,N,N-trimethylammonio)-2,2,2- trifluoroacetophenone, are ideal candidates for initial studies using solid state NMR since they demonstrate a high potency, have a large degree of conformational freedom and bind covalently to the enzyme at the active-site. Both compounds, R414425 and R414983 were successfully synthesised with the incorporation of 13C isotopic labels which, in conjunction with the fluorine atoms already present in their structures, provided the potential for homonuclear and heteronuclear distance measurements. 13 13 13 The rotational resonance technique was used to determine C- C distances in C5-R414983 bound to Electrophorus electricus AChE. The reliability of distance measurements in the presence of broad spectral linewidths was first examined through the measurement of two rigid internuclear distances, indicating that an accuracy of 0.5 Å could be attained using linewidth based estimation of zero-quantum relaxation parameters. Subsequently, the internuclear distance for the benzyl methylene/2-methyl spin pair was determined to be 3.9 ± 0.5 Å and that for the benzyl methylene/quinoline C2 pair to be 3.5 ± 0.5 Å. The use of a rotational resonance echo showed a low level of zero-quantum relaxation under rotational resonance for 13 13 19 one example pair of spins from C5-R414983 bound to Electrophorus electricus AChE. C- F REDOR experiments performed on a dilute rigid standard indicated that a carbon observed scheme where dephasing pulses were also applied to the carbon channel produced significantly more accurate results than similar schemes with dephasing pulses in the fluorine channel. 13C- 19F REDOR was then utilised to quantify the separation of the trifluoromethyl function and 13 13 the C atom at the 2-methyl position in C5-R414983 bound to Electrophorus electricus AChE, providing a distance of 7.1 ± 0.5 Å. The error level for each of the distance measurements is unfortunately high. However, modelling suggests that the determination of a single conformation for the bound inhibitor is restricted by the number of distance measurements presently available rather than the precision of the current values. Significant progress has been made towards elucidation of the first structure for an inhibitor bound to Electrophorus electricus acetylcholinesterase and, for the first time, determination of the conformation of an inhibitor bound to acetylcholinesterase through a means other than x-ray crystallography. Acknowledgements A great number of individuals have contributed to this work in some way or another. The quick mention of these people, carefully tailored to fit in a single side of A4, doesn’t really do justice to them. A reference to ten men in a boat comes to mind, but few people would understand that. Financial support was provided in the form of a CASE studentship from the Engineering and Physical Sciences Research Council in collaboration with Syngenta. Terry Lewis, Peter Howe, John Taylor and Caroline Personeni from Syngenta supplied me with support and technical advice at various points, for which I am very grateful. In addition to the opportunity and the infrastructure necessary to complete this work Tony has frequently exceeded his duties as a supervisor, supporting both my interests outside the lab and those of my wife. A special thanks to those who provided advice on particular areas – Ian, Carsten, Rene, Vincent and Stephan. Paul has helped with multiple sections and has always given freely of his time, while making me do everything the long, hard, correct way. Other members of the lab, past and present, provided helpful discussions on many occasions. Lastly, a big thanks to my family and friends, especially my parents who put in a lot of hard work over the last 27 years to get me to this point and my wife who has probably suffered more than me over the last few months. - iv - Contents Abstract............................................................................................................................ iii Acknowledgements ......................................................................................................... iv Abbreviations and Symbols ............................................................................................. ix Chapter 1 Introduction.............................................................................. 1 1.1 Biological Membranes..................................................................................................1 1.2 Acetylcholine.................................................................................................................3 1.2.1 Nerve Signalling ..............................................................................................3 1.2.2 Cholinergic Signalling.....................................................................................5 1.3 Acetylcholinesterase ...................................................................................................10 1.3.1 Nomenclature................................................................................................10 1.3.2 Macromolecular Structure and Cellular Localisation...............................11 1.3.3 Structure of Catalytic Subunits....................................................................13 1.3.4 Non-cholinergic Roles of Acetylcholinesterase........................................19 1.3.5 Acetylcholinesterase Inhibition...................................................................19 1.4 Nuclear Magnetic Resonance....................................................................................21 1.4.1 The NMR Spectrum.....................................................................................21 1.4.2 Solid State NMR ...........................................................................................25 1.5 Solid State NMR and Acetylcholinesterase.............................................................29 1.6 Project Aims................................................................................................................36 Chapter 2 Synthesis of Labelled Inhibitors............................................. 38 2.1 Overview......................................................................................................................38 2.2 Introduction ................................................................................................................39 - v - 2.2.1 Synthetic Route .............................................................................................39 2.2.2 Labelling Schemes.........................................................................................40 2.2.3 Internuclear Distance Constraints..............................................................42 2.3 Synthesis.......................................................................................................................43 2.3.1 General ...........................................................................................................43 2.3.2 Synthesis of 4-amino-5-fluoro-2-methyl-3-(3-trifluoroacetylbenzyl- oxymethyl)quinoline (R414425)..................................................................43 13 2.3.3 Synthesis of C5-4-amino-5-fluoro-2-methyl-3-(3-trifluoroacetylbenzyl- 13 oxymethyl)quinoline ( C5-R414425)..........................................................48 2.3.4 Synthesis of 4-amino-2-methyl-3-(3-trifluoroacetylbenzyl- oxymethyl)quinoline (R414983)..................................................................52 13 2.3.5 Synthesis of C5-4-amino-2-methyl-3-(3-trifluoroacetylbenzyl- 13 oxymethyl)quinoline ( C5-R414983)..........................................................56 2.4 Discussion....................................................................................................................61 Chapter 3 Characterisation of Inhibitors ................................................ 63 3.1 Overview......................................................................................................................63
Load more

Recommended publications
  • E30 SEM. O.C. Disclosed Is a Compound Represented by the Formula (1) (51) Int
    USOO9453000B2 (12) United States Patent (10) Patent No.: US 9.453,000 B2 Kimura et al. (45) Date of Patent: *Sep. 27, 2016 (54) POLYCYCLIC COMPOUND (56) References Cited (75) Inventors: Teiji Kimura, Tsukuba (JP); Noritaka U.S. PATENT DOCUMENTS Kitazawa, Tsukuba (JP); Toshihiko 3,470,167 A 9, 1969 Sarkar Kaneko, Tsukuba (JP); Nobuaki Sato, 3,989,816 A 1 1/1976 Rajadhyaksha Tsukuba (JP); Koki Kawano, Tsukuba 4,910,200 A 3, 1990 Curtze et al. (JP): Koichi Ito, Tsukuba (JP); 5,281,626 A 1/1994 Oinuma et al. M s Tak ishi Tsukub JP 5,563,162 A 10, 1996 Oku et al. amoru Takaishi Tsukuba (JP); 5,804,577 A 9, 1998 Hebeisen et al. Takeo Sasaki, Tsukuba (JP); Yu 5,985,856 A 11/1999 Stella et al. Yoshida, Tsukuba (JP); Toshiyuki 6,235,728 B1 5, 2001 Golik et al. Uemura, Tsukuba (JP); Takashi Doko, g R 1939. E. al. Its SE E. Shinmyo, 7,138.414 B2 11/2006 Schoenafingereatch et al. et al. sukuba (JP); Daiju Hasegawa, 7,300,936 B2 11/2007 Parker et al. Tsukuba (JP); Takehiko Miyagawa, 7,314,940 B2 1/2008 Graczyk et al. Hatfield (GB); Hiroaki Hagiwara, 7,618,960 B2 11/2009 Kimura et al. Tsukuba (JP) 7,667,041 B2 2/2010 Kimura et al. 7,687,640 B2 3/2010 Kimura et al. 7,713,993 B2 5/2010 Kimura et al. (73) Assignee: EISAI R&D MANAGEMENT CO., 7,737,141 B2 6/2010 Kimura et al. LTD., Tokyo (JP) 7,880,009 B2 2/2011 Kimura et al.
    [Show full text]
  • Territrem and Butyrolactone Derivatives from a Marine-Derived Fungus Aspergillus Terreus
    Mar. Drugs 2014, 12, 6113-6124; doi:10.3390/md12126113 OPEN ACCESS marine drugs ISSN 1660-3397 www.mdpi.com/journal/marinedrugs Article Territrem and Butyrolactone Derivatives from a Marine-Derived Fungus Aspergillus Terreus Xu-Hua Nong 1, Yi-Fei Wang 2, Xiao-Yong Zhang 1, Mu-Ping Zhou 2, Xin-Ya Xu 1 and Shu-Hua Qi 1,* 1 CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica/RNAM Center for Marine Microbiology, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West Xingang Road, Guangzhou, 510301 Guangdong, China; E-Mails: [email protected] (X.-H.N.); [email protected] (X.-Y.Z.); [email protected] (X.-Y.X.) 2 Jinan University, 601 West Huangpu Road, Guangzhou, 510632 Guangdong, China; E-Mails: [email protected] (Y.-F.W.); [email protected] (M.-P.Z.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +86-20-8902-2112; Fax: +86-20-8445-8964. External Editor: Johannes F. Imhoff Received: 17 September 2014; in revised form: 24 November 2014 / Accepted: 8 December 2014 / Published: 17 December 2014 Abstract: Seventeen lactones including eight territrem derivatives (1–8) and nine butyrolactone derivatives (9–17) were isolated from a marine-derived fungus Aspergillus terreus SCSGAF0162 under solid-state fermentation of rice. Compounds 1–3 and 9–10 were new, and their structures were elucidated by spectroscopic analysis. The acetylcholinesterase inhibitory activity and antiviral activity of compounds 1–17 were evaluated. Among them, compounds 1 and 2 showed strong inhibitory activity against acetylcholinesterase with IC50 values of 4.2 ± 0.6, 4.5 ± 0.6 nM, respectively.
    [Show full text]
  • Research Advances and Detection Methodologies for Microbe-Derived Acetylcholinesterase Inhibitors: a Systemic Review
    molecules Review Research Advances and Detection Methodologies for Microbe-Derived Acetylcholinesterase Inhibitors: A Systemic Review Jingqian Su 1,2,3, Huiying Liu 1,2,3, Kai Guo 1,2,3, Long Chen 4, Minhe Yang 3 and Qi Chen 1,2,3,* 1 Fujian Key Laboratory of Innate Immune Biology, Fujian Normal University, Fuzhou 350117, China; [email protected] (J.S.); [email protected] (H.L.); [email protected] (K.G.) 2 Biomedical Research Center of South China, Fujian Normal University, Fuzhou 350117, China 3 College of Life Science, Fujian Normal University, Fuzhou 350117, China; [email protected] 4 Tumor Invasion Microecological Laboratory, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China; [email protected] * Correspondence: [email protected]; Tel.: +86-591-2286-8190 Academic Editor: Derek J. McPhee Received: 9 December 2016; Accepted: 16 January 2017; Published: 23 January 2017 Abstract: Acetylcholinesterase inhibitors (AChEIs) are an attractive research subject owing to their potential applications in the treatment of neurodegenerative diseases. Fungi and bacteria are major producers of AChEIs. Their active ingredients of fermentation products include alkaloids, terpenoids, phenylpropanoids, and steroids. A variety of in vitro acetylcholinesterase inhibitor assays have been developed and used to measure the activity of acetylcholinesterases, including modified Ellman’s method, thin layer chromatography bioautography, and the combined liquid chromatography-mass spectrometry/modified Ellman’s method. In this review, we provide an overview of the different detection methodologies, the microbe-derived AChEIs, and their producing strains. Keywords: Alzheimer’s disease; acetylcholinesterase inhibitors; in vitro assays Acetylcholinesterase is a secretory carboxylesterase present in the central and peripheral nervous systems.
    [Show full text]
  • Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: a Crystallographic, Kinetic and Calorimetric Study
    Article Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study Terrone L. Rosenberry 1, Xavier Brazzolotto 2, Ian R. Macdonald 3, Marielle Wandhammer 2, Marie Trovaslet-Leroy 2,†, Sultan Darvesh 4,5,6 and Florian Nachon 2,* 1 Departments of Neuroscience and Pharmacology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA; [email protected] 2 Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, 91220 Brétigny-sur-Orge, France; [email protected] (X.B.); [email protected] (M.W.); [email protected] (M.T.-L.) 3 Department of Diagnostic Radiology, Dalhousie University, Halifax, NS B3H 4R2, Canada; [email protected] 4 Department of Medical Neuroscience, Dalhousie University, Halifax, NS B3H 4R2, Canada; [email protected] 5 Department of Chemistry, Mount Saint Vincent University, Halifax, NS B3M 2J6, Canada 6 Department of Medicine (Neurology and Geriatric Medicine), Dalhousie University, Halifax, NS B3H 4R2, Canada * Correspondence: [email protected]; Tel.: +33-178-65-1877 † Deceased October 2016. Received: 26 October 2017; Accepted: 27 November 2017; Published: 29 November 2017 Abstract: Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) hydrolyze the neurotransmitter acetylcholine and, thereby, function as coregulators of cholinergic neurotransmission. Although closely related, these enzymes display very different substrate specificities that only partially overlap. This disparity is largely due to differences in the number of aromatic residues lining the active site gorge, which leads to large differences in the shape of the gorge and potentially to distinct interactions with an individual ligand. Considerable structural information is available for the binding of a wide diversity of ligands to AChE.
    [Show full text]
  • X-Ray Structures of Torpedo Californica Acetylcholinesterase Complexed
    X-ray Structures of Torpedo californica Acetylcholinesterase Complexed with (+)-Huperzine A and (-)-Huperzine B: Structural Evidence for an Active Site Rearrangement†,‡ H. Dvir,§,| H. L. Jiang,§,⊥ D. M. Wong,§,| M. Harel,§ M. Chetrit,§ X. C. He,⊥ G. Y. Jin,⊥ G. L. Yu,⊥ X. C. Tang,⊥ I. Silman,| D. L. Bai,*,⊥ and J. L. Sussman*,§ Departments of Structural Biology and Neurobiology, Weizmann Institute of Science, RehoVot 76100, Israel, and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, Peoples Republic of China ReceiVed February 20, 2002; ReVised Manuscript ReceiVed June 26, 2002 ABSTRACT: Kinetic and structural data are presented on the interaction with Torpedo californica acetylcholinesterase (TcAChE) of (+)-huperzine A, a synthetic enantiomer of the anti-Alzheimer drug, (-)-huperzine A, and of its natural homologue (-)-huperzine B. (+)-Huperzine A and (-)-huperzine B bind to the enzyme with dissociation constants of 4.30 and 0.33 µM, respectively, compared to 0.18 µM for (-)-huperzine A. The X-ray structures of the complexes of (+)-huperzine A and (-)-huperzine B with TcAChE were determined to 2.1 and 2.35 Å resolution, respectively, and compared to the previously determined structure of the (-)-huperzine A complex. All three interact with the “anionic” subsite of the active site, primarily through π-π stacking and through van der Waals or C-H‚‚‚π interactions with Trp84 and Phe330. Since their R-pyridone moieties are responsible for their key interactions with the active site via hydrogen bonding, and possibly via C-H‚‚‚π interactions, all three maintain similar positions and orientations with respect to it.
    [Show full text]
  • 1. Magnetic Nanoparticles: from Diagnosis to Therapy
    Research Signpost Trivandrum Kerala, India Recent Advances in Pharmaceutical Sciences VIII, 2018: 1-18 ISBN: 978-81-308-0579-5 Editors: Diego Muñoz-Torrero, Yolanda Cajal and Joan Maria Llobet 1. Magnetic nanoparticles: From diagnosis to therapy M. Antònia Busquets and Joan Estelrich Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry Institute of Nanoscience and Nanotechnology, IN2UB Faculty of Pharmacy and Food Sciences, University of Barcelona Avda Joan XXIII, 27-31, 08028 Barcelona Abstract. Magnetic nanoparticles have proven to be promising theranostic agents, namely tools for therapy and diagnosis. Among them, superparamagnetic iron oxide nanoparticles (SPIONs) highlight for their biocompatibility and reduced toxicity. Here, we describe the synthesis and characterization of SPIONs by co-precipitation of ferric and ferrous salts under mild conditions. These particles were able to accumulate in inflamed areas fact that was increased upon the application of an external magnetic field. Resonance magnetic imaging studies have shown their suitability as negative contrast agents for diagnosis. In addition, hybrid nanoparticles were obtained by incorporating the above described SPIONs into liposomes or nanoemulsions. The findings have confirmed the high potential of these systems for biomedical applications. Introduction The impact of nanotechnology is strongly associated to the development of nanomaterials and nanoparticles (NPs) [1,2]. In particular, magnetic nanoparticles (MNs) present a number of advantages if compared to other Correspondence/Reprint request: Dr. M. Antònia Busquets, Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Avda Joan XXIII, 27-31, 08028 Barcelona. E-mail: [email protected] 2 M. Antònia Busquets & Joan Estelrich nanosystems.
    [Show full text]
  • Catalytic, Theoretical, and Biological Investigation of an Enzyme Mimic Model
    Turkish Journal of Chemistry Turk J Chem (2021) 45: 1270-1278 http://journals.tubitak.gov.tr/chem/ © TÜBİTAK Research Article doi:10.3906/kim-2104-51 Catalytic, theoretical, and biological investigation of an enzyme mimic model Gülcihan GÜLSEREN* Department of Molecular Biology and Genetics, Faculty of Agriculture and Natural Sciences, Konya Food and Agriculture University, Turkey Received: 20.04.2021 Accepted/Published Online: 12.06.2021 Final Version: 27.08.2021 Abstract: Artificial catalyst studies were always stayed at the kinetics investigation level, in this work bioactivity of designed catalyst were shown by the induction of biomineralization of the cells, indicating the possible use of enzyme mimics for biological applications. The development of artificial enzymes is a continuous quest for the development of tailored catalysts with improved activity and stability. Understanding the catalytic mechanism is a replaceable step for catalytic studies and artificial enzyme mimics provide an alternative way for catalysis and a better understanding of catalytic pathways at the same time. Here we designed an artificial catalyst model by decorating peptide nanofibers with a covalently conjugated catalytic triad sequence. Owing to the self-assembling nature of the peptide amphiphiles, multiple action units can be presented on the surface for enhanced catalytic performance. The designed catalyst has shown an enzyme-like kinetics profile with a significant substrate affinity. The cooperative action in between catalytic triad amino acids has shown improved catalytic activity in comparison to only the histidine-containing control group. Histidine is an irreplaceable contributor to catalytic action and this is an additional reason for control group selection. This new method based on the self-assembly of covalently conjugated action units offers a new platform for enzyme investigations and their further applications.
    [Show full text]
  • Druglike Leads for Steric Discrimination Between Substrate
    Chem Biol Drug Des 2011; 78: 495–504 ª 2011 John Wiley & Sons A/S doi: 10.1111/j.1747-0285.2011.01157.x Research Article Drug-like Leads for Steric Discrimination between Substrate and Inhibitors of Human Acetylcholinesterase Scott A. Wildman1,†, Xiange Zheng1,†, One focus of AChE research lies in the development of new drugs David Sept2, Jeffrey T. Auletta3, Terrone L. that could prevent and ⁄ or treat poisoning from organophosphates Rosenberry3 and Garland R. Marshall1,* (OPs), toxic agents commonly used in insecticides as well as in chemical warfare agents (2). OP poisoning causes the inactivation 1Department of Biochemistry and Molecular Biophysics, Washington of AChE that prevents synaptic transmission, leading to muscle University, St. Louis, MO 63110, USA paralysis, hypertension, and malfunction of various organ systems, 2Department of Biomedical Engineering, University of Michigan, Ann ultimately leading to death. Arbor, MI 48109, USA 3Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, Two ligand-binding sites in AChE have been identified, the acylation USA site (A-site) at the base of a deep active-site gorge and the periph- *Corresponding author: Garland R. Marshall, eral site (P-site) near the gorge entrance through which ligands must [email protected] pass on their way to the A-site (3–5). Figure 1 shows the binding Authors contributed equally to this work. gorge of human AChE with acetylcholine modeled into both the A- site (green) and P-site (pink) as described in Methods. OPs are toxic Protection of the enzyme acetylcholinesterase because they covalently react with S203 in the A-site. Wilson and (AChE) from the toxic effects of organophosphate Ginsburg (6,7) conceived complementary oxime compounds that insecticides and chemical warfare agents (OPs) may be provided by inhibitors that bind at the could re-activate OP-poisoned AChE.
    [Show full text]
  • Structural Dynamics of Acetylcholinesterase and Its Implications in Reactivators Design Gianluca Santoni
    Structural dynamics of acetylcholinesterase and its implications in reactivators design Gianluca Santoni To cite this version: Gianluca Santoni. Structural dynamics of acetylcholinesterase and its implications in reactivators design. Biomolecules [q-bio.BM]. Université Grenoble Alpes, 2015. English. NNT : 2015GREAY019. tel-01212481 HAL Id: tel-01212481 https://tel.archives-ouvertes.fr/tel-01212481 Submitted on 6 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Pour obtenir le grade de DOCTEUR DE L’UNIVERSITÉ DE GRENOBLE Spécialité : Physique pour les sciences du vivant Arrêté ministériel : 7 Aout 2006 Présentée par Gianluca SANTONI Thèse dirigée par Martin WEIK et codirigée par Florian NACHON préparée au sein de l’Institut de Biologie Structurale de Grenoble et de l’école doctorale de physique Structural dynamics of acetyl- cholinesterase and its implications in reactivator design Thèse soutenue publiquement le 30/01/2015, devant le jury composé de : Dr. Yves Bourne Directeur de recherche CNRS, AFMB Marseille, Rapporteur Dr. Etienne Derat Maitre de conference, Université Pierre et Marie Curie, Paris, Rapporteur Prof. Pierre-Yves Renard Professeur, Université de Normandie, Rouen, Examinateur Prof. Israel Silman Professeur, Weizmann Institute of Science,Rehovot, Examinateur Dr.
    [Show full text]
  • Mechanistic Studies of Biomimetic Reactions by Synthetic Enzyme Mimics by William Michael Hart-Cooper a Dissertation Submitted I
    Mechanistic Studies of Biomimetic Reactions by Synthetic Enzyme Mimics By William Michael Hart-Cooper A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Chemistry in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Kenneth N. Raymond, Co-chair Professor Robert G. Bergman, Co-chair Professor Alexander Katz Summer 2015 Abstract Mechanistic Studies of Biomimetic Reactions by Synthetic Enzyme Mimics By William Michael Hart-Cooper Doctor of Philosophy in Chemistry University of California, Berkeley Professor Kenneth N. Raymond, Co-chair Professor Robert G. Bergman, Co-chair Chapter 1. A brief introduction to common synthetic host structures and justification for the work described herein is provided. Chapter 2. The development of 1 and related hosts as a new class terpene synthase mimics that catalyze intramolecular Prins cyclizations. The property of water exclusion is observed. Host 1 is also shown to compensate for the gem-disubstituent effect. Chapter 3. The development of new terephthalamide hosts enabled an investigation of the effect of host structure on the enantio- and diastereoselectivity of these reactions, as well as a simple kinetic analysis. Rate accelerations and turnover numbers are notably high. Chapter 4. The mechanism of proton transfer in an archetypal enzyme mimic is studied using amide hydrogen deuterium exchange (HDX) kinetics. Collectively, these data shed light on the role of acid, base and water-mediated proton transfer in a synthetic active site with relevance to proton-mediated catalysis. Moreover, the emergent mechanism of solvent-occupied proton transfer raises the prospect of designable hosts with properties that are unique to the integration of their parts Chapter 5.
    [Show full text]
  • Proton Affinity Studies of Nickel N2S2 Complexes and Control of Aggregation
    JBIC Journal of Biological Inorganic Chemistry https://doi.org/10.1007/s00775-019-01671-4 ORIGINAL PAPER Proton afnity studies of nickel N2S2 complexes and control of aggregation Nicholas A. Arnet1 · Nattamai Bhuvanesh1 · Marcetta Y. Darensbourg1 Received: 1 April 2019 / Accepted: 22 May 2019 © Society for Biological Inorganic Chemistry (SBIC) 2019 Abstract The thiolate ligands of [NiFe]-H2ase enzymes have been implicated as proton-binding sites for the reduction/oxidation of + H /H2. This study examines the ligand efect on reactivity of NiN2S2 complexes with an array of acids in methanol solu- tion. UV–Vis absorption spectroscopy is utilized to observe the transformation from the monomeric species to a trimetallic complex that is formed after proton-induced ligand dissociation. Nickel complexes with a fexible (propyl and ethyl) N to N linker were found to readily form the trimetallic complex with acids as weak as ammonium (pKa = 10.9 in methanol). A more constrained nickel complex with a diazacycloheptane N to N linker required stronger acids such as 2,2-dichloroacetic + acid (pKa = 6.38 in methanol) to form the trimetallic complex and featured the formation of an NiN 2S2H complex with acetic acid (pK a = 9.63 in methanol). The most strained ligand, which featured a diazacyclohexane backbone, readily disso- ciated from the nickel center upon mixture with acids with pKa ≤ 9.63 and showed no evidence of a trimetallic species with any acid. This research highlights the dramatic diferences in reactivity with proton sources that can be imparted by minor alterations to ligand geometry and strain. Graphical abstract Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s0077 5-019-01671 -4) contains supplementary material, which is available to authorized users.
    [Show full text]
  • Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
    Int. J. Biol. Sci. 2018, Vol. 14 341 Ivyspring International Publisher International Journal of Biological Sciences 2018; 14(3): 341-357. doi: 10.7150/ijbs.23247 Review Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders Ghulam Hussain1,3, Azhar Rasul4,5, Haseeb Anwar3, Nimra Aziz3, Aroona Razzaq3, Wei Wei1,2, Muhammad Ali4, Jiang Li2, Xiaomeng Li1 1. The Key Laboratory of Molecular Epigenetics of MOE, Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China 2. Dental Hospital, Jilin University, Changchun 130021, China 3. Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan 4. Department of Zoology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan 5. Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science. 2-1 Hirosawa, Wako, Saitama 351-0198 Japan Corresponding authors: Professor Xiaomeng Li, The Key Laboratory of Molecular Epigenetics of Ministry of Education, Institute of Genetics and Cytology, Northeast Normal University, 5268 People's Street, Changchun, Jilin 130024, P.R. China. E-mail: [email protected] Tel: +86 186 86531019; Fax: +86 431 85579335 or Professor Jiang Li, Department of Prosthodontics, Dental Hospital, Jilin University, 1500 Tsinghua Road, Changchun, Jilin 130021, P.R. China. E-mail: [email protected] © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2017.10.09; Accepted: 2017.12.18; Published: 2018.03.09 Abstract Neurodegenerative diseases are conventionally demarcated as disorders with selective loss of neurons.
    [Show full text]